These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15210522

  • 1. Reaction time and movement time after embryonic cell implantation in Parkinson disease.
    Gordon PH, Yu Q, Qualls C, Winfield H, Dillon S, Greene PE, Fahn S, Breeze RE, Freed CR, Pullman SL.
    Arch Neurol; 2004 Jun; 61(6):858-61. PubMed ID: 15210522
    [Abstract] [Full Text] [Related]

  • 2. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group.
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [Abstract] [Full Text] [Related]

  • 3. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S.
    N Engl J Med; 2001 Mar 08; 344(10):710-9. PubMed ID: 11236774
    [Abstract] [Full Text] [Related]

  • 4. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial.
    McRae C, Cherin E, Yamazaki TG, Diem G, Vo AH, Russell D, Ellgring JH, Fahn S, Greene P, Dillon S, Winfield H, Bjugstad KB, Freed CR.
    Arch Gen Psychiatry; 2004 Apr 08; 61(4):412-20. PubMed ID: 15066900
    [Abstract] [Full Text] [Related]

  • 5. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
    Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Müller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H, German Coenzyme Q(10) Study Group.
    Arch Neurol; 2007 Jul 08; 64(7):938-44. PubMed ID: 17502459
    [Abstract] [Full Text] [Related]

  • 6. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A, Parkinson Study Group.
    Arch Neurol; 2004 Jul 08; 61(7):1044-53. PubMed ID: 15262734
    [Abstract] [Full Text] [Related]

  • 7. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, Louis ED, Mulligan T, Foster PS, Shenal BV, Armaghani SJ, Jacobson C, Wu S, Crucian G.
    Arch Neurol; 2006 May 08; 63(5):729-35. PubMed ID: 16682542
    [Abstract] [Full Text] [Related]

  • 8. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
    Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, Snow B, Olanow CW.
    Mov Disord; 1998 May 08; 13(3):383-93. PubMed ID: 9613726
    [Abstract] [Full Text] [Related]

  • 9. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort InvestigatorsDepartment of Neurology, University of Rochester, 1351 Mt Hope Ave, Ste 220, Rochester, NY 14620, USA. kevin.biglan@ctcc.rochester.edu.
    Arch Neurol; 2009 May 08; 66(5):563-70. PubMed ID: 19433655
    [Abstract] [Full Text] [Related]

  • 10. Foot-tapping rate as an objective outcome measure for Parkinson disease clinical trials.
    Gunzler SA, Pavel M, Koudelka C, Carlson NE, Nutt JG.
    Clin Neuropharmacol; 2009 May 08; 32(2):97-102. PubMed ID: 18978495
    [Abstract] [Full Text] [Related]

  • 11. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov 08; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 12. Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.
    Scholtissen B, Verhey FR, Adam JJ, Weber W, Leentjens AF.
    Clin Neuropharmacol; 2006 Nov 08; 29(5):276-85. PubMed ID: 16960473
    [Abstract] [Full Text] [Related]

  • 13. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH, Klasser M, Reichmann H.
    Fortschr Neurol Psychiatr; 2008 Oct 08; 76(10):594-9. PubMed ID: 18833504
    [Abstract] [Full Text] [Related]

  • 14. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.
    Int J Clin Pract; 2009 Apr 08; 63(4):613-23. PubMed ID: 19222614
    [Abstract] [Full Text] [Related]

  • 15. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM, Foote KD, Fernandez HH, Sudhyadhom A, Rodriguez RL, Zeilman P, Jacobson CE, Okun MS.
    Neurosurgery; 2008 Oct 08; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [Abstract] [Full Text] [Related]

  • 16. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
    Scholtissen B, Verhey FR, Adam JJ, Prickaerts J, Leentjens AF.
    J Neurol Sci; 2006 Oct 25; 248(1-2):259-65. PubMed ID: 16756999
    [Abstract] [Full Text] [Related]

  • 17. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
    Goetz CG, Damier P, Hicking C, Laska E, Müller T, Olanow CW, Rascol O, Russ H.
    Mov Disord; 2007 Jan 15; 22(2):179-86. PubMed ID: 17094088
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of a self-supervised home exercise program with a physiotherapist-supervised exercise program on the motor symptoms of Parkinson's disease.
    Lun V, Pullan N, Labelle N, Adams C, Suchowersky O.
    Mov Disord; 2005 Aug 15; 20(8):971-5. PubMed ID: 15838853
    [Abstract] [Full Text] [Related]

  • 19. Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.
    Murata M, Hasegawa K, Kanazawa I, Japan Zonisamide on PD Study Group.
    Neurology; 2007 Jan 02; 68(1):45-50. PubMed ID: 17200492
    [Abstract] [Full Text] [Related]

  • 20. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG, Carter JH, Carlson NE.
    Arch Neurol; 2007 Mar 02; 64(3):319-23. PubMed ID: 17353373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.